Addition of Rituximab Improves the Outcome of Adult Patients with CD20-Positive, Ph-Negative, B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL): Results of the Randomized Graall-R 2005 Study
Sébastien Maury(Assistance Publique – Hôpitaux de Paris), Hervé Dombret(University of London Institute in Paris), Françoise Huguet(Centre Hospitalier Universitaire de Toulouse), Mathilde Hunault(Centre National de la Recherche Scientifique), Véronique Lhéritier(Hospices Civils de Lyon), Patrice Chevallier(Hotel Dieu Hospital), Norbert Ifrah(Institut National du Cancer), Thibaut Leguay(Centre Hospitalier Universitaire de Bordeaux), U Hess(Université Paris Cité), Sylvie Chevret(Saint Louis University Hospital), Norbert Vey(Centre de Recherche en Cancérologie de Marseille), Marie C. Béné(Centre Hospitalier Universitaire de Nantes), Xavier Thomas(Hôpital Lyon Sud), Martine Escoffre‐Barbe(Université Rennes 2), Kheïra Beldjord(Inserm), Nicolas Boissel(Inserm), Dominik Heim(University Hospital of Basel), Yves Chalandon(University of Geneva), Jean‐Pierre Marolleau(Centre Hospitalier Universitaire Amiens-Picardie), Thorsten Braun(Humboldt-Universität zu Berlin)
Cited by 44
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k